Mylan Pharm is investing in a new cancer treatment gene therapy. They have projected the cost of final clinical trials to be $90,000,000 (now) and for those to take 4 years to complete. They then have to get FDA approval, which will take an additional 2 years. The regulatory departmen has given the projections below. If your company goal is a MARR of 6%, a) What is the expected NPV b) Should you recommend this project? 30% chance of failure – No Revenue 50% chance of approval by FDA, 6 years from now, Revenue $20,000,000/ year for years 6-15 20% chance wider approval by FDA, 6 years from now, Revenue $55,000,000/year for years 6-15

Intermediate Financial Management (MindTap Course List)
13th Edition
ISBN:9781337395083
Author:Eugene F. Brigham, Phillip R. Daves
Publisher:Eugene F. Brigham, Phillip R. Daves
Chapter14: Real Options
Section: Chapter Questions
Problem 3MC: Tropical Sweets is considering a project that will cost $70 million and will generate expected cash...
icon
Related questions
Question
a) -$25,391,153, No
b) $23,879,899, Yes
c) $24,043,600, Yes
d) $25,497,589, yes
Mylan Pharm is investing in a new cancer treatment gene therapy. They have projected the cost of final clinical trials to be $90,000,000 (now)
and for those to take 4 years to complete. They then have to get FDA approval, which will take an additional 2 years. The regulatory department
has given the projections below. If your company goal is a MARR of 6%,
a) What is the expected NPV
b) Should you recommend this project?
30% chance of failure – No Revenue
50% chance of approval by FDA, 6 years from now, Revenue $20,000,000/ year for years 6-15
20% chance wider approval by FDA, 6 years from now, Revenue $55,000,000/year for years 6-15
Transcribed Image Text:Mylan Pharm is investing in a new cancer treatment gene therapy. They have projected the cost of final clinical trials to be $90,000,000 (now) and for those to take 4 years to complete. They then have to get FDA approval, which will take an additional 2 years. The regulatory department has given the projections below. If your company goal is a MARR of 6%, a) What is the expected NPV b) Should you recommend this project? 30% chance of failure – No Revenue 50% chance of approval by FDA, 6 years from now, Revenue $20,000,000/ year for years 6-15 20% chance wider approval by FDA, 6 years from now, Revenue $55,000,000/year for years 6-15
Expert Solution
steps

Step by step

Solved in 2 steps with 2 images

Blurred answer
Knowledge Booster
Accounting for Income Taxes
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, finance and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Intermediate Financial Management (MindTap Course…
Intermediate Financial Management (MindTap Course…
Finance
ISBN:
9781337395083
Author:
Eugene F. Brigham, Phillip R. Daves
Publisher:
Cengage Learning
Principles of Accounting Volume 2
Principles of Accounting Volume 2
Accounting
ISBN:
9781947172609
Author:
OpenStax
Publisher:
OpenStax College
Corporate Fin Focused Approach
Corporate Fin Focused Approach
Finance
ISBN:
9781285660516
Author:
EHRHARDT
Publisher:
Cengage
Cornerstones of Cost Management (Cornerstones Ser…
Cornerstones of Cost Management (Cornerstones Ser…
Accounting
ISBN:
9781305970663
Author:
Don R. Hansen, Maryanne M. Mowen
Publisher:
Cengage Learning
Essentials of Business Analytics (MindTap Course …
Essentials of Business Analytics (MindTap Course …
Statistics
ISBN:
9781305627734
Author:
Jeffrey D. Camm, James J. Cochran, Michael J. Fry, Jeffrey W. Ohlmann, David R. Anderson
Publisher:
Cengage Learning
Financial Management: Theory & Practice
Financial Management: Theory & Practice
Finance
ISBN:
9781337909730
Author:
Brigham
Publisher:
Cengage